Sign Up to like & get recommendations! 0
Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.3783
Abstract: As patients receiving definitive chemoradiotherapy (dCRT) for oesophageal squamous cell carcinoma (ESCC) are heterogeneous, we aimed to identify prognostic factors and failure patterns after dCRT. From 2006 to 2015, 327 patients who received dCRT for… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "International journal of surgery case reports"
DOI: 10.1016/j.ijscr.2022.107116
Abstract: INTRODUCTION Esophageal carcinosarcoma is a rare malignancy composed of both carcinoma and sarcoma-like spindle cells. This tumor is usually diagnosed before treatment due to its unique macroscopic appearance but accurate diagnose is difficult even via… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz259.008
Abstract: Abstract Background To analyze patterns of failure for patients with LA-NSCLC receiving definitive chemoradiotherapy and build a nomogram for predicting the failure patterns in these patients. Methods Clinicopathological materials of patients between 2013 and 2016… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "BJS Open"
DOI: 10.1093/bjsopen/zrac125
Abstract: Abstract Background The literature lacks robust evidence comparing definitive chemoradiotherapy (dCRT) with neoadjuvant chemoradiotherapy and surgery (nCRS) for oesophageal squamous cell carcinoma (ESCC). This study aimed to compare long-term survival of these approaches in patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Diseases of The Esophagus"
DOI: 10.1093/dote/doaa087.72
Abstract: Ongoing randomized controlled trials seek to evaluate the potential organ-preservation strategy of definitive chemoradiotherapy as a primary treatment for esophageal cancer. This population-based cohort study aimed to assess survival following definitive chemoradiotherapy (DCR) with or… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000007920
Abstract: Abstract The aim of this study was to evaluate the efficacy and acute toxicity of definitive chemoradiotherapy (CRT) and radiotherapy (RT) alone as initial treatment in patients aged 75 years and older with locally advanced… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Asian Journal of Endoscopic Surgery"
DOI: 10.1111/ases.12658
Abstract: We herein report a case of mediastinoscopic salvage esophagectomy for recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy in a previously pneumonectomized patient. A 66‐year‐old man with a medical history of left‐sided pneumonectomy for lung… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.am2020-ct282
Abstract: Background: For patients with unresectable esophageal cancer (EC), definitive chemoradiotherapy (dCRT) is a standard treatment option. Platinum plus fluoropyrimidine-based regimens are comparable in dCRT and are considered standard options; however, overall survival (OS) is still… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.4_suppl.104
Abstract: 104 Background: JCOG0909, a single-arm confirmatory trial of definitive chemoradiotherapy (dCRT) including salvage treatment, demonstrated promising efficacy and safety for cStage II/III (UICC-TNM 6th) esophageal cancer (EC) (Ito Y, ASCO 2018). Radiation (RT) fields included… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2018.03.04
Abstract: Background Clinical outcomes appear to differ between patients with residual or recurrent esophageal cancer after definitive chemoradiotherapy. We aimed to identify the patients most likely to benefit from this high-risk surgery, divided by the patients… read more here.